We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
- Authors
Bleie, Ø; Semb, A G; Grundt, H; Nordrehaug, J E; Vollset, S E; Ueland, P M; Nilsen, D W T; Bakken, A M; Refsum, H; Nygård, O K
- Abstract
A high level of total homocysteine (tHcy) is a risk marker for cardiovascular disease (CVD), and is related to inflammation. We wanted to test the effect of homocysteine-lowering B-vitamin therapy, as used in the Western Norway B-vitamin Intervention Trial (WENBIT), on inflammatory markers associated with atherosclerosis.
- Publication
Journal of internal medicine, 2007, Vol 262, Issue 2, p244
- ISSN
0954-6820
- Publication type
Journal Article
- DOI
10.1111/j.1365-2796.2007.01810.x